معرفی
Dr. Davinder S. Jassal is a Full Professor in the Department of Internal Medicine, Department of Radiology, and Department of Physiology and Pathophysiology at the University of Manitoba, affiliated with the Rady Faculty of Health Sciences. He serves as Head of the Section of Cardiology and is the Principal Investigator of the Cardiovascular Imaging Laboratory at the Institute of Cardiovascular Sciences, St. Boniface Albrechtsen Research Centre.
His educational background includes an MD from the University of Manitoba (1998), residency in Internal Medicine (1998–2001), Adult Cardiology training at Dalhousie University, and a clinical and research fellowship in Cardiac Imaging (echocardiography, CT, MRI) at Massachusetts General Hospital, Harvard Medical School.
Dr. Jassal's research focuses on multimodality non-invasive cardiovascular imaging for assessing heart failure, particularly in high-risk populations such as women undergoing breast cancer chemotherapy. His work emphasizes translational applications in Cardio-Oncology, Women’s Heart Health, and Sudden Cardiac Death. Key research initiatives include the SHIELD-HF study (SGLT2 inhibitors for cardioprotection), the CANFLAX study (flax 'milk' for preventing chemotherapy-induced heart failure), and the EXACT 2.0 trial (aerobic exercise to mitigate anthracycline cardiotoxicity). His lab utilizes echocardiography, cardiac CT, and cardiac MRI to evaluate structural, electrical, and functional cardiac changes.
No scientific awards were mentioned in the provided text.
Dr. Jassal joined the University of Manitoba in 2006 as an Academic Clinician Scientist, dividing his time equally between clinical work in the Acute Cardiac Care Unit and cardiac imaging, and translational research. He leads a research team within the Cardiovascular Imaging Laboratory at St. Boniface Hospital, collaborating with technicians such as Mr. David YC Cheung. While specific grants are not detailed, his research program is actively investigating novel cardioprotective strategies in oncology settings, with implications for public health and agricultural innovation in Manitoba.
The Cardiovascular Imaging Laboratory is a key component of his research infrastructure, supporting clinical trials and imaging-based translational studies focused on preventing chemotherapy-induced cardiotoxicity.
